Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07727785
PHASE1
A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole
Sponsor: Boehringer Ingelheim
View on ClinicalTrials.gov
Summary
The goal of this study is to find out whether pramipexole tablets made at two different production sites are handled in the same way by the body.
Official title: Bioequivalence of Two Pramipexole Tablets Following Oral Administration in Healthy Participants (an Open-label, Randomised, Multiple-dose, Two-way Crossover Trial)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2026-08-05
Completion Date
2026-09-28
Last Updated
2026-09-15
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Sifrol®
Pramipexole tablets
DRUG
Mirapex®
Pramipexole tablets
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany